Cyanotech Corporation reported its fourth quarter and fiscal year 2025 earnings results, showing a steady growth in net sales and improvements in financial performance. For the fourth quarter, the company achieved net sales of $6.3 million, marking an increase of $330,000 or 5.5% compared to the same period last year. Annual net sales reached $24.2 million, up by $1.1 million or 5% from the previous fiscal year. The company's gross profit for the fourth quarter was $1.7 million, with a gross profit margin of 27.7%, significantly higher than the $675,000 gross profit and 11.3% margin recorded in the fourth quarter of fiscal year 2024. For the entire fiscal year, Cyanotech's gross profit amounted to $6.9 million, with a gross profit margin of 28.4%, compared to $5.9 million and a 25.8% margin last year. This improvement was driven by higher production volumes and increased efficiencies in production. Cyanotech also reported a shift in its product sales mix, with bulk spirulina and bulk astaxanthin products growing by 53% and 74%, respectively. However, this growth was partially offset by a 5% decline in packaged sales. The company is focused on expanding market awareness through strategic initiatives, including the hiring of a Head of Sales to deepen channel expansion. Looking ahead, Cyanotech plans to manage inventory levels carefully to meet the heightened demand for its products while maintaining a conservative approach to cash management.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cyanotech Corporation published the original content used to generate this news brief on June 23, 2025, and is solely responsible for the information contained therein.
Comments